Market Currents
Alnylam Pharmaceuticals (ALNY -1.7%) and Genzyme, a Sanofi (SNY -0.4%) company, team up to...
-
Monday, October 22, 2012, 3:59 PM ETAlnylam Pharmaceuticals (ALNY -1.7%) and Genzyme, a Sanofi (SNY -0.4%) company, team up to develop and commercialize RNAi therapeutics targeting transthyretin for the treatment of transthyretin-mediated amyloidosis in Japan and other Asia-Pacific countries.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
